Categories: Automobile

AAMPACT CEO Thomas Fischer exclusive: The mood is positive

The AAMPACT CEO is open about the major challenges facing the independent spare parts and repair market. He believes that a fair future can only be achieved internationally, and explains why repair shops will always be needed.

- Advertisement -

How do you view the announcement of the Chinese automotive industry to start a European offensive? When will it reach the open aftermarket? 

- Advertisement -

The Chinese have their work cut out for them. They need to ask themselves: What are the typical wear parts, and how can they be transported to Europe? How can we ensure availability? Or should more parts be produced in Europe? How will employees in the workshops be trained? Chinese brands will try to set up authorised workshops in Europe. They are already doing this with sales. The online business has not been all that successful. Now, they are looking for retail partners.

- Advertisement -

It’s not just different manufacturers; it’s also different cars. Entertainment systems are important, and cars are becoming a ‘home away from home’. “Software-designed vehicles” are already on the way.

- Advertisement -

These developments affect more than just cars from China. In general, I believe that the independent market, which our association represents, has the same prerequisites to participate in these developments as authorised repair shops do. Mechanics are neither smarter or dumber because of where they work. The problem is that vehicle manufacturers are very selective with their information, despite clear legal regulations stating that all market participants must be treated equally by car manufacturers. This is a battle we have been fighting for a long time.

- Advertisement -

Read the full interview here on Gateway to Automotive.

- Advertisement -

 

- Advertisement -
TheNewsMarketTeam

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

4 weeks ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago